tilomisole has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloom, R; Dheer, SK; Fenichel, RL; Grant, NH; Gregory, FJ; Scott, DP | 1 |
| Alburn, HE; Bloom, R; Fenichel, RL; Gregory, FJ; Schreck, PA | 1 |
2 other study(ies) available for tilomisole and Lung Neoplasms
| Article | Year |
|---|---|
Immunomodulating activity of 3-(p-chlorophenyl)thiazolo-[3,2-a] benzimidazole-2-acetic acid (Wy-18,251, NSC 310633) in mice implanted with Lewis lung tumor. Effect of Wy-18,251 on lymphocyte proliferation and phagocytosis.
Topics: Adjuvants, Immunologic; Animals; B-Lymphocytes; Benzimidazoles; Concanavalin A; Levamisole; Lipopolysaccharides; Lung Neoplasms; Lymphocyte Activation; Macrophages; Male; Mice; Phagocytosis; T-Lymphocytes | 1983 |
Immunomodulating and antimetastatic activity of 3-(p-chlorophenyl) thiazolo[3,2-a]benzimidazole-2-acetic acid (Wy-18,251, NSC 310633).
Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Benzimidazoles; Cell Division; Immunity; Leukemia P388; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Rosette Formation; T-Lymphocytes | 1980 |